MannKind Corporation (MNKD) Drops 9.4% on January 06

Equities Staff |

MannKind Corporation (MNKD) was one of the Russell 2000's biggest losers for Wednesday January 06 as the stock slid 9.4% to $0.68, a loss of $-0.0703 per share. Starting at an opening price of $0.69 a share, the stock traded between $0.64 and $0.83 over the course of the trading day. Volume was 19.5 million shares over 33,248 trades, against an average daily volume of 6.42 million shares and a total float of 409.49 million.

The losses send MannKind Corporation down to a market cap of $277.35 million. In the last year, MannKind Corporation has traded between $7.88 and $0.70, and its 50-day SMA is currently $2.19 and 200-day SMA is $3.95.

MannKind Corp is a development stage company engaged in the discovery, development, and commercialization of therapeutic products for diseases such as diabetes.

MannKind Corporation is based out of Valencia, CA and has some 287 employees. Its CEO is Duane M. Desisto.

For a complete fundamental analysis analysis of MannKind Corporation, check out Equities.com’s Stock Valuation Analysis report for MNKD. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Sack Lunch Productions Inc

Sack Lunch Productions Inc is an entertainment company. The Company, through its subsidiaries, is engaged in event management, production service, film production and distribution services.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Wealthfront

Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…